1. Home
  2. AADI vs RFIL Comparison

AADI vs RFIL Comparison

Compare AADI & RFIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • RFIL
  • Stock Information
  • Founded
  • AADI 2011
  • RFIL 1979
  • Country
  • AADI United States
  • RFIL United States
  • Employees
  • AADI N/A
  • RFIL N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • RFIL Electrical Products
  • Sector
  • AADI Health Care
  • RFIL Technology
  • Exchange
  • AADI Nasdaq
  • RFIL Nasdaq
  • Market Cap
  • AADI 33.6M
  • RFIL 44.4M
  • IPO Year
  • AADI N/A
  • RFIL N/A
  • Fundamental
  • Price
  • AADI $1.57
  • RFIL $4.08
  • Analyst Decision
  • AADI Buy
  • RFIL Strong Buy
  • Analyst Count
  • AADI 2
  • RFIL 1
  • Target Price
  • AADI $5.00
  • RFIL $4.00
  • AVG Volume (30 Days)
  • AADI 294.5K
  • RFIL 33.4K
  • Earning Date
  • AADI 08-07-2024
  • RFIL 09-12-2024
  • Dividend Yield
  • AADI N/A
  • RFIL N/A
  • EPS Growth
  • AADI N/A
  • RFIL N/A
  • EPS
  • AADI N/A
  • RFIL N/A
  • Revenue
  • AADI $23,840,000.00
  • RFIL $61,094,000.00
  • Revenue This Year
  • AADI $4.21
  • RFIL N/A
  • Revenue Next Year
  • AADI $8.61
  • RFIL $8.31
  • P/E Ratio
  • AADI N/A
  • RFIL N/A
  • Revenue Growth
  • AADI 26.97
  • RFIL N/A
  • 52 Week Low
  • AADI $1.28
  • RFIL $2.51
  • 52 Week High
  • AADI $7.24
  • RFIL $4.65
  • Technical
  • Relative Strength Index (RSI)
  • AADI 50.71
  • RFIL 59.73
  • Support Level
  • AADI $1.46
  • RFIL $4.04
  • Resistance Level
  • AADI $1.69
  • RFIL $4.41
  • Average True Range (ATR)
  • AADI 0.10
  • RFIL 0.26
  • MACD
  • AADI 0.02
  • RFIL -0.02
  • Stochastic Oscillator
  • AADI 67.75
  • RFIL 46.23

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About RFIL RF Industries Ltd.

RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.

Share on Social Networks: